[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-367407-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-367407-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","the-role-of-cxc-chemokines-and-receptors-in-breast-cancer","The role of CXC chemokines and receptors in breast cancer","","CXC chemokines are cytokines with chemotactic activity, and accumulating studies link their dysregulation to tumor progression across multiple cancer types. Breast cancer remains a leading diagnosed and fatal cancer in women, driven by mechanisms including invasion, metastasis, angiogenesis, and inflammation in which chemokines and receptors participate. The CXCR family and their ligands regulate tumor proliferation and shape the tumor microenvironment and immune responses. This review evaluates CXCRs and CXC chemokines as therapeutic targets or biomarkers, summarizes expression and prognostic relevance, and discusses current challenges and future prospects.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/the-role-of-cxc-chemokines-and-receptors-in-breast-cancer/367407/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/the-role-of-cxc-chemokines-and-receptors-in-breast-cancer/367407.png","ImageObject",300,407,{"name":42,"@type":43},"WPS_1786070896","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-06","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",7,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What are CXC chemokines and why are they important in cancer?","Question",{"text":63,"@type":64},"CXC chemokines are cytokines with chemotactic properties. Studies associate CXC chemokines with dysregulation across cancers and with tumor advancement.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How is the immune system related to breast cancer progression?",{"text":68,"@type":64},"Cancer immune-editing describes elimination, equilibrium, and escape stages. The immune response and immune cell infiltration help determine prognosis and therapy response in breast cancer.",{"name":70,"@type":61,"acceptedAnswer":71},"Why are CXCRs and their ligands considered therapeutic targets or biomarkers?",{"text":72,"@type":64},"CXCRs are expressed on cancer and immune cells and regulate tumor microenvironment and immune responses. Their multifaceted functions support their evaluation as targets or biomarkers for personalized therapy.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},367407,1790543520,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},549768072016,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","Clinical and Experimental Medicine (2025) 25:128 [https://doi.org/10.1007/s10238-025-01662-7](https://doi.org/10.1007/s10238-025-01662-7)  \nThe role of CXC chemokines and receptors in breast cancer  \nMahdi Masrour1,2 · Aysan Moeinafshar1 · Amirhossein Poopak1 · Sepideh Razi3,4 · Nima Rezaei4,5,6  \nReceived: 17 September 2024 / Accepted: 1 April 2025 / Published online: 25 April 2025 © The Author(s) 2025  \nAbstract  \nCXC chemokines are a class of cytokines possessing chemotactic properties. Studies indicate that CXC chemokines exhibit dysregulation in miscellaneous cancer categories and are significantly associated with the advancement of tumors. Breast cancer is a commonly diagnosed and fatal cancer among the female population. Breast cancer pathogenesis and progression involve various mechanisms, including invasion, metastasis, angiogenesis, and inflammation. Chemokines and their receptors are involved in all of these processes. The CXC chemokine receptors (CXCRs) and their related ligands have attracted considerable attention due to their multifaceted functions in facilitating and controlling tumor proliferation. CXCRs are expressed by both cancer cells and immune cells, and they play a crucial role in regulating the tumor microenvironment and the immune response. This review aims to assess the potential of CXCRs and CXC chemokines as therapeutic targets or biomarkers for personalized therapy. Additionally, it provides an overview of the current understanding of the expression, function, and prognostic relevance of CXCRs in breast cancer. Furthermore, the challenges and potential prospects pertaining to CXCR investigation in breast cancer are deliberated.  \nKeywords Breast cancer · chemokines · CXC chemokines · CXC receptors · CXCRs  \nIntroduction  \nOn an international scale, breast cancer ranks among the top five most prevalent types of cancer. Projections indicate that the incidence of breast cancer will increase by 1.5 times the current rate within the next two decades [1–4] . Mammographic screening, improved methods of breast cancer  \n* Nima Rezaei  \n[rezaei_nima@yahoo.com](rezaei_nima@yahoo.com); [rezaei_nima@tums.ac.ir](rezaei_nima@tums.ac.ir)  \n1 School of Medicine, Tehran University of Medical Sciences (TUMS), Tehran, Iran  \n2 Center for Orthopedic Trans-Disciplinary Applied Research, Tehran University of Medical Sciences, Tehran, Iran  \n3 Cancer Immunology Project (CIP), Universal Scientific and Education Network (USERN), Tehran, Iran  \n4 Research Center for Immunodeficiencies, Children’s Medical Center Hospital, Tehran University of Medical Sciences, Dr. Qarib St, Keshavarz Blvd, Tehran 14194, Iran  \n5 Department of Immunology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran  \n6 Network of Immunity in Infection, Malignancy and Autoimmunity (NIIMA), Universal Scientific Education and Research Network (USERN), Tehran, Iran  \ndiagnosis, and increased availability of effective treatments have all contributed to a decline in the mortality rate associated with breast cancer [5] . Breast cancers are divided into intrinsic molecular subtypes based on immunohistochemistry differences in the expression of progesterone and estrogen receptors, as well as human epidermal growth factor receptor-2 (HER2) in the tumor [6, 7] .  \nAccording to cancer immune-editing hypothesis, the immune system performs two roles in tumor development: one that promotes tumor growth and the other that mediates tumor elimination. There are three main stages in the relations between the tumor and the immune system: elimination, equilibrium, and escape [8] . Therefore, it is possible to predict both the prognosis and the patient's response to therapy based on the immune cell infiltration [9, 10] .  \nThe cellular phenotype and cell subsets involved in inflammation within the microenvironment will determine the immune system's influence on breast cancer [11, 12] . Chemokines are cytokines that govern leukocyte activation and migrat","cbCaifMDDG16X2D2","https://ap.wps.com/l/cbCaifMDDG16X2D2","pdf",928279,22,"English","# Abstract\n# Introduction\n# Breast cancer\n# Overview of CXC receptors","[{\"question\":\"What are CXC chemokines and why are they important in cancer?\",\"answer\":\"CXC chemokines are cytokines with chemotactic properties. Studies associate CXC chemokines with dysregulation across cancers and with tumor advancement.\"},{\"question\":\"How is the immune system related to breast cancer progression?\",\"answer\":\"Cancer immune-editing describes elimination, equilibrium, and escape stages. The immune response and immune cell infiltration help determine prognosis and therapy response in breast cancer.\"},{\"question\":\"Why are CXCRs and their ligands considered therapeutic targets or biomarkers?\",\"answer\":\"CXCRs are expressed on cancer and immune cells and regulate tumor microenvironment and immune responses. Their multifaceted functions support their evaluation as targets or biomarkers for personalized therapy.\"}]","The role of CXC chemokines and receptors in breast cancer | PDF",1790170651,55,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4b51f2b09c998dfde8f65b1c2b35bf10.webp",983,1305,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c388009900886a8bc0b1306aed09852a.webp",982,1304,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/417a00a5917047646ba5804d8b931e03.webp",981,1303,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/36da421d7262bf9ba504db1ab464f742.webp",980,1301]